Other
Emergency Department Patient
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Emergency Department Patient is an early-stage landscape with 0 programs across 1 company. The most active players are INSYS Therapeutics Inc.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed9 · 75%
Withdrawn2 · 17%
Terminated1 · 8%
Clinical Trials
Trial Activity
12 trials
IV Acetaminophen as Adjuvant Analgesic to Hydromorphone - Emergency Department Patients
Completed·—·Phase 3·NCT03553498·162 enrolled
Ondansetron and the QT Interval In Adult Emergency Department Patients
Completed·—·N/A·NCT01759420·28 enrolled
The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients
Completed·—·N/A·NCT00448123·127 enrolled
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
Terminated·—·Phase 4·NCT03043430·10 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)